- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Swedish Pharmaceuticals & Biotech Strong Balance Sheet Stocks
UPDATED May 18, 2022
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
102 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LIDDSLIDDS | kr8.60 | 15.6% | -15.7% | kr292.3m | n/a | PS82.2x | n/a | n/a | ||
| PEXA BPExA | kr0.78 | -12.4% | -54.1% | kr27.1m | n/a | PS11.8x | n/a | n/a | ||
| MVIR BMedivir | kr7.68 | 3.6% | -0.6% | kr428.0m | kr17.88 | PS26.9x | E76.5% | n/a | ||
| PROBProbi | kr291.00 | 0.7% | -40.4% | kr3.3b | n/a | PS44.5x | E13.9% | 0.4% | ||
| ODIODI Pharma | kr5.50 | 7.0% | 21.7% | kr83.7m | n/a | PS182.5x | n/a | n/a | ||
| MOBMoberg Pharma | kr2.31 | -3.8% | -54.5% | kr104.4m | n/a | PS-6.6x | n/a | n/a | ||
| NXTCLNextCell Pharma | kr7.89 | -0.1% | -47.6% | kr271.3m | n/a | PS49.3x | n/a | n/a | ||
| ANNXAnnexin Pharmaceuticals | kr0.71 | -5.1% | -65.2% | kr100.9m | n/a | PB2.2x | n/a | n/a | ||
| COMBICombiGene | kr8.07 | 2.7% | 2.7% | kr159.8m | n/a | PS5.5x | n/a | n/a | ||
| VICOVicore Pharma Holding | kr22.60 | 18.6% | -3.8% | kr1.6b | kr90.33 | PB5.6x | E-1.1% | n/a | ||
| BIOG BBioGaia | kr101.70 | -1.5% | 20.1% | kr10.3b | kr124.00 | PS46.2x | E8.4% | 0.7% | ||
| ACEAscelia Pharma | kr19.72 | -2.6% | -41.5% | kr663.9m | kr61.50 | PB2.4x | E42.2% | n/a | ||
| BIOA BBioArctic | kr76.65 | 7.4% | -0.8% | kr6.7b | kr225.00 | PS318.4x | E116.5% | 0% | ||
| XBRANEXbrane Biopharma | kr78.90 | 0.8% | -36.8% | kr2.0b | kr235.00 | PS425.3x | E155.8% | n/a | ||
| IRLAB AIRLAB Therapeutics | kr37.00 | 5.1% | 0% | kr1.9b | kr38.00 | PS44.9x | E-43.0% | n/a | ||
| IBT BInfant Bacterial Therapeutics | kr70.00 | -1.5% | -33.3% | kr785.8m | n/a | PB2.1x | n/a | n/a | ||
| ONCOZOncoZenge | kr2.95 | 1.7% | -69.1% | kr34.5m | kr2.75 | PS-8.9x | E-32.6% | n/a | ||
| MCAPMedCap | kr172.80 | 0.3% | -16.5% | kr2.6b | n/a | PS25.2x | n/a | n/a | ||
| HNSAHansa Biopharma | kr57.10 | 8.0% | -60.5% | kr2.5b | kr227.20 | PS46x | E1.2% | n/a | ||
| KDEVKarolinska Development | kr2.65 | 4.1% | 70.5% | kr715.1m | kr5.40 | PS4.3x | E-144.0% | n/a | ||
| EURI BEuropean Institute of Science | kr0.08 | -2.4% | -46.7% | kr6.9m | n/a | PS13x | n/a | n/a | ||
| BIOVIC BBiovica International | kr32.40 | 4.9% | -20.6% | kr923.0m | n/a | PS224.8x | E198.4% | n/a | ||
| TOLToleranzia | kr1.00 | -2.0% | -7.8% | kr110.3m | n/a | PS3.8x | n/a | n/a | ||
| RESPRespiratorius | kr0.47 | -4.9% | -67.6% | kr136.2m | n/a | PB2.4x | n/a | n/a |